Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Atelosteogenesis type 2

R Newbury-Ecob¹

¹Clinical Genetics Service, Bristol Royal Hospital for Sick Children, UK.

Journal of Medical Genetics

|February 25, 1998

Summary

This summary is machine-generated.

Atelosteogenesis type 2 (AO2) is a lethal skeletal disorder causing severe limb shortening. Mutations in the diastrophic dysplasia sulphate transporter (DTDST) gene cause both AO2 and diastrophic dysplasia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

De novo variants in CNOT3 cause a variable neurodevelopmental disorder.

European journal of human genetics : EJHG·2019

Same author

Expanding the genotypic spectrum of Perrault syndrome.

Clinical genetics·2016

Same author

CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.

Journal of medical genetics·2006

Same author

Inherited pericentric inversion (X)(p11.4q11.2) associated with delayed puberty and obesity in two brothers.

Cytogenetic and genome research·2005

Same author

The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy.

Journal of medical genetics·2005

Same author

Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.

Journal of medical genetics·2003

Same journal

Longest surviving patient with a homozygous splice-altering <i>EGFR</i> pathogenic variant presenting with skin autoinflammation and a Bartter-like salt-losing tubulopathy.

Journal of medical genetics·2026

Same journal

Functional characterisation and pathological significance of variants of <i>MEF2C</i> promoter in tetralogy of Fallot.

Journal of medical genetics·2026

Same journal

Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disability.

Journal of medical genetics·2026

Same journal

Inherited retinal disease genes with dual inheritance patterns: insights from the IRD-PT registry.

Journal of medical genetics·2026

Same journal

Interpreting <i>TP53</i> variants: somatic mosaicism and <i>ERCC6L2</i>-driven clonal evolution.

Journal of medical genetics·2026

Same journal

Review of estimates of birth incidence and population prevalence over time and between countries of the rare neurodevelopmental condition Prader-Willi syndrome.

Journal of medical genetics·2026

See all related articles

Area of Science:

Genetics
Skeletal Dysplasias
Molecular Biology

Background:

Atelosteogenesis type 2 (AO2) is a severe, neonatally lethal skeletal dysplasia.
Key features include extreme limb shortening, poor ossification, facial dysmorphism, cleft palate, and limb abnormalities.
Phenotypic similarities with diastrophic dysplasia (DTD) suggested a shared genetic cause.

Purpose of the Study:

To investigate the genetic basis of Atelosteogenesis type 2.
To confirm the molecular link between AO2 and diastrophic dysplasia.

Main Methods:

Genetic analysis of patients with Atelosteogenesis type 2.
Mutation screening of the diastrophic dysplasia sulphate transporter (DTDST) gene.

Main Results:

Related Experiment Videos

Mutations in the DTDST gene were identified as the cause of Atelosteogenesis type 2.
This confirms a shared genetic etiology between AO2 and DTD.

Conclusions:

Mutations in the DTDST gene are responsible for Atelosteogenesis type 2.
Understanding the DTDST gene's role clarifies the molecular basis of related skeletal dysplasias.